1887

Journal of General Virology header logo

Volume 88, Issue 9

Functional consequences of attenuating mutations in the haemagglutinin–neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain Free

Abstract

Wild-type mumps viruses (MuVs) are highly neurotropic and, prior to widespread vaccination programmes, were a major cause of viral meningitis and encephalitis in most developed countries. At present, there are no markers for virus attenuation, apart from the failure of a passaged isolate to produce clinical symptoms in vaccinees. Indeed, some MuV vaccines have retained residual neurovirulence properties and have caused aseptic meningitis in vaccinees. Three amino acid changes associated with the neuroattenuation of a wild-type MuV strain were identified previously. This study evaluated the impact of these changes on the function of the respective proteins. The data demonstrated that the Ser→Asp amino acid substitution at position 466 in the haemagglutinin–neuraminidase protein resulted in decreased receptor binding and neuraminidase activity, the Ala/Thr→Thr selection in the fusion protein resulted in decreased fusion activity, and the Ile→Val substitution in the polymerase resulted in increased replicative/transcriptional activity. These data suggest a polygenic component (i.e. specific and inter-related roles of these amino acid changes) to MuV neuroattenuation.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82935-0
2007-09-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/9/2533.html?itemId=/content/journal/jgv/10.1099/vir.0.82935-0&mimeType=html&fmt=ahah

References

  1. Afzal M. A., Yates P. J., Minor P. D. 1998; Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. J Infect Dis 177:265–266 [CrossRef]
     [Google Scholar]
  2. Aguilar H. C., Matreyek K. A., Filone C. M., Hashimi S. T., Levroney E. L., Negrete O. A., Bertolotti-Ciarlet A., Choi D. Y., McHardy I. other authors 2006; N -glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J Virol 80:4878–4889 [CrossRef]
     [Google Scholar]
  3. Amexis G., Fineschi N., Chumakov K. 2001; Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. Virology 287:234–241 [CrossRef]
     [Google Scholar]
  4. Amexis G., Rubin S., Chatterjee N., Carbone K., Chumakov K. 2003; Identification of a new genotype H wild-type mumps virus strain and its molecular relatedness to other virulent and attenuated strains. J Med Virol 70:284–286 [CrossRef]
     [Google Scholar]
  5. Aminoff D. 1961; Methods for the quantitative estimation of N -acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J 81:384–392
     [Google Scholar]
  6. Aygun A. D., Kabakus N., Celik I., Turgut M., Yoldas T., Gok U., Guler R. 2001; Long-term neurological outcome of acute encephalitis. J Trop Pediatr 47:243–247 [CrossRef]
     [Google Scholar]
  7. Bagai S., Lamb R. A. 1995; Individual roles of N -linked oligosaccharide chains in intracellular transport of the paramyxovirus SV5 fusion protein. Virology 209:250–256 [CrossRef]
     [Google Scholar]
  8. Bairoch A., Bucher P., Hofmann K. 1997; The PROSITE database, its status in 1997. Nucleic Acids Res 25:217–221 [CrossRef]
     [Google Scholar]
  9. Bang H. O., Bang J. 1943; Involvement of the central nervous system in mumps. Acta Med Scand 113:487–505
     [Google Scholar]
  10. Bankamp B., Kearney S. P., Liu X., Bellini W. J., Rota P. A. 2002; Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay. J Virol 76:7073–7081 [CrossRef]
     [Google Scholar]
  11. Beghi E., Nicolosi A., Kurland L. T., Mulder D. W., Hauser W. A., Shuster L. 1984; Encephalitis and aseptic meningitis, Olmsted County. Minnesota: 1950–1981; I. Epidemiology. Ann Neurol 16:283–294 [CrossRef]
     [Google Scholar]
  12. Brown E. G., Dimock K., Wright K. E. 1996; The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J Infect Dis 174:619–622 [CrossRef]
     [Google Scholar]
  13. Buchholz U. J., Finke S., Conzelmann K. K. 1999; Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251–259
     [Google Scholar]
  14. Caksen H., Ustunbas H. B. 2003; A fatal case of acute transverse myelitis associated with mumps. J Emerg Med 24:341–342 [CrossRef]
     [Google Scholar]
  15. Carbone K. M., Rubin S. 2007; Mumps virus. In Fields Virology , 5th edn. pp 1527–1542 Edited by Knipe D. M., Howley P. M., Griffin D. E., Lamb R. A., Martin M. A., Roizman B., Strauss S. E. Philadelphia: Lippincott Williams & Wilkins;
     [Google Scholar]
  16. Centers for Disease Control and Prevention; 2006; Mumps epidemic – Iowa, 2006. MMWR Morb Mortal Wkly Rep 55:366–368
     [Google Scholar]
  17. Clarke D. K., Sidhu M. S., Johnson J. E., Udem S. A. 2000; Rescue of mumps virus from cDNA. J Virol 74:4831–4838 [CrossRef]
     [Google Scholar]
  18. Cohen H. A., Ashkenazi A., Nussinovitch M., Amir J., Hart J., Frydman M. 1992; Mumps-associated acute cerebellar ataxia. Am J Dis Child 146:930–931
     [Google Scholar]
  19. Conzelmann K. K. 2004; Reverse genetics of mononegavirales. Curr Top Microbiol Immunol 283:1–41
     [Google Scholar]
  20. Crennell S., Takimoto T., Portner A., Taylor G. 2000; Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol 7:1068–1074 [CrossRef]
     [Google Scholar]
  21. Elango N., Varsanyi T. M., Kovamees J., Norrby E. 1988; Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol 69:2893–2900 [CrossRef]
     [Google Scholar]
  22. Furesz J., Contreras G. 1990; Vaccine-related mumps meningitis – Canada. Can Dis Wkly Rep 16:253–254
     [Google Scholar]
  23. Galazka A. M., Robertson S. E., Kraigher A. 1999; Mumps and mumps vaccine: a global review. Bull World Health Organ 77:3–14
     [Google Scholar]
  24. Gupta R. K., Best J., MacMahon E. 2005; Mumps and the UK epidemic 2005. BMJ 330:1132–1135 [CrossRef]
     [Google Scholar]
  25. Jablonski S. A., Luo M., Morrow C. D. 1991; Enzymatic activity of poliovirus RNA polymerase mutants with single amino acid changes in the conserved YGDD amino acid motif. J Virol 65:4565–4572
     [Google Scholar]
  26. Kovamees J., Rydbeck R., Orvell C., Norrby E. 1990; Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res 17:119–129 [CrossRef]
     [Google Scholar]
  27. Liu Y., Zhu J., Feng M. G., Tien P., Gao G. F. 2004; Six-helix bundle assembly and analysis of the central core of mumps virus fusion protein. Arch Biochem Biophys 421:143–148 [CrossRef]
     [Google Scholar]
  28. Love A., Rydbeck R., Kristensson K., Orvell C., Norrby E. 1985; Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. J Virol 53:67–74
     [Google Scholar]
  29. McGinnes L., Sergel T., Reitter J., Morrison T. 2001; Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity. Virology 283:332–342 [CrossRef]
     [Google Scholar]
  30. Merz D. C., Server A. C., Waxham M. N., Wolinsky J. S. 1983; Biosynthesis of mumps virus F glycoprotein: non-fusing strains efficiently cleave the F glycoprotein precursor. J Gen Virol 64:1457–1467 [CrossRef]
     [Google Scholar]
  31. Miller E., Goldacre M., Pugh S., Colville A., Farrington P., Flower A., Nash J., MacFarlane L., Tettmar R. 1993; Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children. Lancet 341:979–982 [CrossRef]
     [Google Scholar]
  32. Moll M., Kaufmann A., Maisner A. 2004; Influence of N -glycans on processing and biological activity of the Nipah virus fusion protein. J Virol 78:7274–7278 [CrossRef]
     [Google Scholar]
  33. Moss B., Elroy-Stein O., Mizukami T., Alexander W. A., Fuerst T. R. 1990; New mammalian expression vectors. Nature 348:91–92 [CrossRef]
     [Google Scholar]
  34. Muller R., Poch O., Delarue M., Bishop D. H., Bouloy M. 1994; Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J Gen Virol 75:1345–1352 [CrossRef]
     [Google Scholar]
  35. Ogata H., Oka K., Mitsudome A. 1992; Hydrocephalus due to acute aqueductal stenosis following mumps infection: report of a case and review of the literature. Brain Dev 14:417–419 [CrossRef]
     [Google Scholar]
  36. Okazaki K., Tanabayashi K., Takeuchi K., Hishiyama M., Yamada A. 1992; Molecular cloning and sequence analysis of the mumps virus gene encoding the L protein and the trailer sequence. Virology 188:926–930 [CrossRef]
     [Google Scholar]
  37. Paterson R. G., Lamb R. A. 1990; RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol 64:4137–4145
     [Google Scholar]
  38. Peltola H., Davidkin I., Paunio M., Valle M., Leinikki P., Heinonen O. P. 2000; Mumps and rubella eliminated from Finland. JAMA 284:2643–2647 [CrossRef]
     [Google Scholar]
  39. Plemper R. K., Compans R. W. 2003; Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation. J Virol 77:4181–4190 [CrossRef]
     [Google Scholar]
  40. Plumet S., Herschke F., Bourhis J. M., Valentin H., Longhi S., Gerlier D. 2007; Cytosolic 5′-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS ONE 2:e279 [CrossRef]
     [Google Scholar]
  41. Poch O., Sauvaget I., Delarue M., Tordo N. 1989; Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J 8:3867–3874
     [Google Scholar]
  42. Poch O., Blumberg B. M., Bougueleret L., Tordo N. 1990; Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol 71:1153–1162 [CrossRef]
     [Google Scholar]
  43. Rima B. K., Roberts M. W., McAdam W. D., Martin S. J. 1980; Polypeptide synthesis in mumps virus-infected cells. J Gen Virol 46:501–505 [CrossRef]
     [Google Scholar]
  44. Rotbart H. A. 2000; Viral meningitis. Semin Neurol 20:277–292 [CrossRef]
     [Google Scholar]
  45. Rubin S. A., Pletnikov M., Taffs R., Snoy P. J., Kobasa D., Brown E. G., Wright K. E., Carbone K. M. 2000; Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J Virol 74:5382–5384 [CrossRef]
     [Google Scholar]
  46. Rubin S. A., Amexis G., Pletnikov M., Li Z., Vanderzanden J., Mauldin J., Sauder C., Malik T., Chumakov K., Carbone K. M. 2003; Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J Virol 77:11616–11624 [CrossRef]
     [Google Scholar]
  47. Rubin S. A., Afzal M. A., Powell C. L., Bentley M. L., Auda G. R., Taffs R. E., Carbone K. M. 2005; The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study. J Infect Dis 191:1123–1128 [CrossRef]
     [Google Scholar]
  48. Savage E., Ramsay M., White J., Beard S., Lawson H., Hunjan R., Brown D. 2005; Mumps outbreaks across England and Wales in 2004: observational study. BMJ 330:1119–1120 [CrossRef]
     [Google Scholar]
  49. Segawa H., Yamashita T., Kawakita M., Taira H. 2000; Functional analysis of the individual oligosaccharide chains of Sendai virus fusion protein. J Biochem (Tokyo) 128:65–72 [CrossRef]
     [Google Scholar]
  50. Sergel T., McGinnes L. W., Peeples M. E., Morrison T. G. 1993; The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 193:717–726 [CrossRef]
     [Google Scholar]
  51. Server A. C., Smith J. A., Waxham M. N., Wolinsky J. S., Goodman H. M. 1985; Purification and amino-terminal protein sequence analysis of the mumps virus fusion protein. Virology 144:373–383 [CrossRef]
     [Google Scholar]
  52. Slater P. E., Anis E., Leventhal A. 1999; The control of mumps in Israel. Eur J Epidemiol 15:765–767 [CrossRef]
     [Google Scholar]
  53. Smallwood S., Hovel T., Neubert W. J., Moyer S. A. 2002; Different substitutions at conserved amino acids in domains II and III in the Sendai L RNA polymerase protein inactivate viral RNA synthesis. Virology 304:135–145 [CrossRef]
     [Google Scholar]
  54. Sugiura A., Yamada A. 1991; Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 10:209–213 [CrossRef]
     [Google Scholar]
  55. Tanabayashi K., Takeuchi K., Okazaki K., Hishiyama M., Yamada A. 1992; Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: both F and HN proteins are required for cell fusion. Virology 187:801–804 [CrossRef]
     [Google Scholar]
  56. Timmons G. D., Johnson K. P. 1970; Aqueductal stenosis and hydrocephalus after mumps encephalitis. N Engl J Med 283:1505–1507 [CrossRef]
     [Google Scholar]
  57. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350–4354 [CrossRef]
     [Google Scholar]
  58. Tsurudome M., Yamada A., Hishiyama M., Ito Y. 1986; Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody. J Gen Virol 67:2259–2265 [CrossRef]
     [Google Scholar]
  59. Ueda K., Miyazaki C., Hidaka Y., Okada K., Kusuhara K., Kadoya R. 1995; Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet 346:701–702
     [Google Scholar]
  60. von Messling V., Cattaneo R. 2003; N -linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion. J Virol 77:10202–10212 [CrossRef]
     [Google Scholar]
  61. von Messling V., Milosevic D., Devaux P., Cattaneo R. 2004; Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function. J Virol 78:7894–7903 [CrossRef]
     [Google Scholar]
  62. Waxham M. N., Server A. C., Goodman H. M., Wolinsky J. S. 1987; Cloning and sequencing of the mumps virus fusion protein gene. Virology 159:381–388 [CrossRef]
     [Google Scholar]
  63. Wyatt L. S., Moss B., Rozenblatt S. 1995; Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210:202–205 [CrossRef]
     [Google Scholar]
  64. Zimmer G., Trotz I., Herrler G. 2001; N -glycans of F protein differentially affect fusion activity of human respiratory syncytial virus. J Virol 75:4744–4751 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82935-0
Loading
Functional consequences of attenuating mutations in the haemagglutinin–neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain
J. Gen. Virol. 88, 2533 (2007); https://doi.org/10.1099/vir.0.82935-0
/content/journal/jgv/10.1099/vir.0.82935-0
/content/journal/jgv/10.1099/vir.0.82935-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error